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1. Introduction 
Human immunodeficiency virus (HIV) results in acquired immune deficiency syndrome 
(AIDS) and is characterized by a serious disorder of the immune system in which the 
protective defenses against infection cannot function leaving the individual vulnerable to 
severe infections and conditions. This results in opportunistic infections causing an 
unfavourable outcome. Since its discovery in 1981 when the first cases were described, 
HIV/AIDS continues to affect people globally. According to the UNAIDS (Joint United 
Nations Programme on HIV/AIDS) and WHO (World Health Organization) 2009 AIDS 
epidemic update report, the estimated number of people living with HIV worldwide in 2008 
was 33.4 million (UNAIDS 2009). Ultimately there is a high prevalence of HIV infection 
among patients admitted to hospitals as well as a high prevalence of AIDS patients as a 
result of opportunistic infections related to their HIV status or advanced AIDS (Mbanya, 
Ateudjieu et al. 2010).  
2. Bacterial colonization 
A major risk factor for bacterial colonization is immunosuppression subsequently making 
HIV-infected individuals ideal candidates (Craven, Steger et al. 1996). Bacterial colonization 
refers to the presence of bacteria in a host but does not cause a specific immune response or 
infection. However, if the relationship between the host and bacterial agent is changed - such 
as immunosuppression of the host, this episode can result in infections (Mandell, Bennett et al. 
2005). Colonization therefore seems to contribute significantly to the development of 
nosocomial infections in HIV-positive patients (Petrosillo, Pagani et al. 2003).  
Colonization is the first step of microbial infection. It is the establishment of the pathogen at 
the suitable portal of entry for example, host tissues that are in contact with the external 
environment. Sites of entry include the conjunctiva, the digestive tract, the respiratory tract 
and the urogenital tract. Organisms such as Staphylococcus aureus have been found to have 
high rates of nasal colonization in HIV-infected patients (Raviglione, Mariuz et al. 1990; 
Weinke, Schiller et al. 1992). Additionally other body cavities may also provide productive 
environments for bacterial colonization. The oral cavity is proximal and contiguous with the 
trachea and is therefore a portal for respiratory pathogen colonization. The teeth and other 
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oral mucosal surfaces particularly in ICU patients operate as reservoirs for respiratory 
pathogen colonization (Raghavendran, Mylotte et al. 2007). 
3. HIV and nosocomial infections 
A nosocomial (hospital-acquired) infection is one in which there is no evidence that the 
infection was present or in an incubation period at the time of hospital admission except 48 
hours after admission. The condition is classified as an infection when it is manifested as a 
clinical disease and not a colonization where microorganisms are present but have no harmful 
effects on the patient’s health. However, asymptomatic patients are considered infected if the 
body fluid or body site that is normally sterile (e.g. blood or cerebrospinal fluid) contains 
pathogenic microorganisms (Emori and Gaynes 1993). Nosocomial infections constitute a 
significant public health concern. They contribute to long hospital-stays and additional health 
care costs and are a significant cause of morbidity and mortality in hospital environments 
(Petrosillo, Pagani et al. 2003; Singh, Goering et al. 2006). Nosocomial infections are common 
and not always avoidable because of the large turnover of patients with underlying conditions. 
Furthermore their immune systems are often in a weakened state. Horizontal transmission 
from one patient to another creates an opportunity for the spread of hospital pathogens. 
Various invasive surgical procedures such as indwelling catheters and medical devices bypass 
the natural body-protective barriers. Prior antimicrobial therapy and inappropriate use of 
antimicrobial agents resulting in the emergence of resistant strains are traditional risk factors 
for acquiring infections in the hospitals. Nosocomial infections are therefore a major challenge 
to the patients’ safety in the hospital setting and HIV as an additional factor has lead to an 
increase in morbidity and mortality. This can be explained by the ability of opportunistic 
pathogens and microorganisms that are normally non-pathogenic to cause disease in 
immunocompromised individuals (Emori and Gaynes 1993; Craven, Steger et al. 1996; 
Vandenesch, Naimi et al. 2003; Singh, Goering et al. 2006; Panis, Matsuo et al. 2009). There are 
several pathogenic processes that are involved in the progression to AIDS in HIV-infected 
individuals such as: depletion in CD4 lymphocytes, defects in B lymphocytes, neutrophil 
dysfunction and the breakdown of the integument as a result of AIDS-related dermatological 
conditions for example bacterial and fungal dermatoses and Kaposi's sarcoma. These 
individual factors have significant implications regarding host susceptibility to nosocomial 
infections (Duse 1999). Noscomial infections appear to be more common in HIV-positive 
individuals with AIDS as opposed to HIV-negative individuals (Angus and Wax 2001). 
Studies have suggested that HIV-infected or AIDS patients are at high risk of acquiring 
nosocomial infections particularly sepsis and bacteraemia due to the implantation of invasive 
intravascular medical devices (Gobbi, Maggi et al. 1998; Tumbarello, Tacconelli et al. 1998; 
Laing 1999; Petrosillo, Pagani et al. 2003; Japiassú, Amâncio et al. 2010). Nosocomial urinary 
tract and respiratory tract infections are also common in HIV-infected AIDS patients following 
bacterial colonization (Petrosillo, Nicastri et al. 2005).  
3.1 Bacteraemia  
Bacteraemia or bloodstream infections are among the most severe of hospital-acquired 
infections and have been shown to cause significant mortality and prolonged hospital-stays 
in patients with HIV (Tumbarello, Tacconelli et al. 1998). Previous studies have shown that 
an increase in these bloodstream infections is associated with HIV infections (Beuheza, 
Beckelman et al. 1989; Fife, Crane et al. 1990).  
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3.1.1 Etiological agents 
Coagulase-negative staphylococci have been implicated as important causes of nosocomial 
bloodstream infections particularly in patients that are immunocompromised (Tumbarello, 
Tacconelli et al. 1995; Pagano, Tacconelli et al. 1997) and in those infected with HIV (Weinke, 
Schiller et al. 1992; Tumbarello, Tacconelli et al. 1996; Tumbarello, Tacconelli et al. 1998). 
Globally, Staphylococcus aureus is the second most common pathogen that is responsible for 
causing bloodstream infections (Fluit, Jones et al. 2000; Luzzaro, Vigano et al. 2002) and in 
European countries it is the leading cause of nosocomial bloodstream infections (Luzzaro, 
Vigano et al. 2002). S. aureus is also the most common pathogen isolated from all 
bloodstream infections in the US (Shorr, Tabak et al. 2006). Bloodstream infections caused by 
these organisms are associated with a high frequency of life-threatening complications such 
as metastatic infections and infective endocarditis (del Rio, Cervera et al. 2009). S. aureus has 
also shown to be responsible for a significant number of in-hospital deaths in patients with 
long-term catheters, cardiovascular, orthopaedic and other medical devices (Chu, Crosslin et 
al. 2005). Methicillin-resistant strains of S. aureus also pose a major problem in nosocomial 
bloodstream infections (del Rio, Cervera et al. 2009).  
Other studies have suggested an increased risk of nosocomial bloodstream infections due to 
aerobic gram-negative bacilli such as Pseudomonas aeruginosa, Klebsiella pneumoniae and 
Escherichia coli in patients that were HIV-infected particularly in those having invasive 
devices (Hickey and Shanson 1993; Sanford 1995; Zurlo and Lane 1997; Tumbarello, 
Tacconelli et al. 1998). Nontyphoidal Salmonella species is an infrequent cause of hospital 
infections (Jaspan 2008). 
3.1.2 Clinical manifestations 
Bloodstream infections may be defined as the presence of viable bacteria in the blood 
(bacteraemia) with a documented positive blood culture result and the presence of clinical 
symptoms of systemic infection (Garner, Jarvis et al. 1988). Primary bloodstream infection is 
a bloodstream infection without a documented primary source of infection (portal of entry 
or site of infection) and can be distinguished from a secondary bloodstream infection which 
is a bloodstream infection secondary to a localised site of infection – wound infection, skin 
and soft-tissue infection, biliary tract infection and pneumonia (Seifert 2009). Infections 
usually associated with secondary bloodstream infections include deep-seated abscesses, 
osteomyelitis and endocarditis (Fowler, Olsen et al. 2003). It has been reported that 
approximately one third of patients with S. aureus bloodstream infections develop local 
complications or distant septic metastases and affect the epidural space and intervertebral 
discs, bone and joints particularly when prosthetic material and native and prosthetic 
cardiac valves are being used (Ringberg, Thoren et al. 2000; Fowler, Olsen et al. 2003). 
Visceral abscesses in the spleen and kidney may also develop (del Rio, Cervera et al. 2009). 
Risk factors associated with complicated S. aureus bloodstream infections include the 
presence of persistent bacteraemia which is defined as the presence of positive blood 
cultures after 72-96 hours of appropriate treatment, the presence of skin lesions suggesting 
distant metastases, persistent fever and community acquisition (Fowler, Olsen et al. 2003).  
Bloodstream infections are a major cause of illness in patients infected with HIV. A high 
percentage of bloodstream infections, ranging from 10% to 63% were observed in 
hospitalised HIV-infected individuals presenting with fever in a number of studies 
conducted in Sub-Saharan Africa (Archibald, den Dulk et al. 1998; Ssali, Kamya et al. 1998; 
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McDonald, Archibald et al. 1999; Peters, Zijlstra et al. 2004). Another study showed that 
bloodstream infection was associated with recent HIV diagnosis. Almost half the patients 
with bloodstream infections presented with a temperature of greater than 38oC. Lower T 
CD4+ counts were also strongly associated with those patients having bloodstream 
infections. Symptoms of abdominal illness such as nausea, vomiting and loss of appetite 
were also associated with bloodstream infections caused by pathogens (Varma, McCarthy et 
al. 2010). HIV-infected patients may be predisposed to bloodstream infections due to several 
conditions such as defective cell-mediated immunity, altered B-cell function with a 
consequent lack of serum opsonins against some encapsulated bacteria and qualitative and 
quantitative deficits of neutrophils leading to an increase in the susceptibility of the patient 
to bacterial and fungal infections (Mertins, Ortona et al. 1990; Zurlo and Lane 1997).  
3.1.3 Management 
The clinical microbiology laboratory plays an important part in the management of patients 
with bloodstream infections. A highly specific indicator of bloodstream infections is the 
culturing of pathogenic microorganisms from blood. In addition antimicrobial susceptibility 
testing (AST) may assist in the choice of antimicrobial therapy to be administered (Bohte, van 
Furth et al. 1995; Chalasani, Valdecanas et al. 1995; Fine, Smith et al. 1996). The early and rapid 
administration of antimicrobial treatment to infected patients has initially shown to decrease 
mortality (Leibovici, Konisberger et al. 1992). However, due to the emergence of antibiotic 
resistance there is a need to develop new antimicrobial agents (Ibrahim, Sherman et al. 2000). 
It is recommended that for those patients that are infected with coagulase-negative 
staphylococci due to the presence of catheters, the catheter should be removed and a short 
course (5-7 days) of antibiotics administered. If the patient has endovascular hardware 
present, persistent fever or bacteraemia may be experienced after the catheter has been 
removed, then a long course of antibiotics may be required (O'Grady and Chertow 2011).  
The choice of antibiotics for enterococcal bloodstream infections depends on the 
susceptibility of the infecting isolate due to antibiotic resistance. Ampicillin is the preferred 
choice of drug for the treatment of ampicillin-susceptible enterococci. If the pathogen is 
resistant to ampiciliin, vancomycin should be used if the isolate is vancomycin-susceptible. 
Enterococci resistant to both ampicillin and vancomycin can be treated with new 
oxazolidinones, linezolid or lipopeptides, daptomycin. However, this depends on 
susceptibility testing (O'Grady and Chertow 2011). Some studies have shown that 
combination therapy may be more effective than monotherapy. This was seen in a number 
of patients with enterococcal bloodstream infections in which the catheter was not removed 
and a combination of ampicillin and gentamicin was used (Sandoe, Witherden et al. 2002). 
For gram-negative bacilli removal of short-term catheters followed by 5-7 days of systemic 
antibiotic therapy is suggested based on antimicrobial susceptibility test results. Usually 
fourth generation cephalosporins, carbapenems or a combination of β-lactam and β-
lactamase inhibitor may be used (O'Grady and Chertow 2011). However, extended-
spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae should not be 
treated with cephalosporins or piperacilin-tazobactam even if they may be susceptible as 
treatment with these drugs has been associated with poor clinical outcome (Paterson, Ko et 
al. 2001; Jacoby and Munoz-Price 2005). 
Fluconazole may be used to treat individuals with bloodstream infections as a result of 
Candida species. Alternative therapy includes echinocandins as first-line therapy and lipid 
formulations of amphotericin B (Mora-Duarte, Betts et al. 2002; Reboli, Roststein et al. 2007). 
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A confirmed catheter-related bloodstream infection for gram-positive organisms requires at 
least two positive results drawn from different sites. These infections are difficult to treat 
unless the infected catheter is removed (Cotton, Gill et al. 1987; Peces, Gago et al. 1997). 
3.2 Urinary tract infections 
Other common nosocomial infections are associated with the urinary tract. Nosocomial 
urinary tract infection is a major infection acquired in both hospitals and nursing homes. In 
most cases these infections are commonly related to catheterization. Bacteriuria is a term 
referring to bacteria in the urine (Mandell, Bennett et al. 2005). Insertion of a catheter may 
predispose the bladder to the introduction of organisms that may colonize the site of 
insertion. Any disconnection of the catheter from the collection tube or breakage of the 
closed system may result in bacteriuria. The collection bag is drained regularly and if the 
lumen of the drainage tube is contaminated with bacteria, this provides a portal of entry for 
bacteria to the drainage bag, collection tube and catheter. A biofilm which secures the 
bacteria against the catheter or mucosal surface protects the bacteria from the mechanical 
flow of urine, host defences and antibiotics (Warren 2001). The rate of urinary tract 
infections particularly related to the use of urinary catheters plays a significant role in 
nosocomial infection in HIV patients (Gobbi, Maggi et al. 1998).  
3.2.1 Etiological agents 
Common organisms isolated from urinary tract infections include Escherichia coli, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus epidermis, 
enterococci and Candida species (Warren 2001). Uropathic E. coli are responsible for most 
urinary tract infections. The E. coli serogroups most often implicated as the cause of high 
proportion of infection are O1, O2, O4, O6, O7, O8, O75, O150 and O18ab (Roberts and 
Phillips 1979; Rosen, Hooton et al. 2007). Hospital environments are a significant 
determinant of the type of organisms causing urinary tract infections. Staphylococci, 
enterococci, Proteus, Klebsiella, Enterobacter and Pseudomonas species are most often 
isolated from inpatients whereas E. coli infection predominate in the outpatient 
population (Bronsema, Adams et al. 1993). Corynebacterium urealyticum (Corynebacterium 
group D2) has been identified as an important nosocomial pathogen (Soriano, Aguado et 
al. 1990).  
3.2.2 Pathogenesis  
Urinary tract infections are as a result of the interaction between bacterial virulence and the 
biologic and behavioural factors in the host. Bacteria may invade and spread within the 
urinary tract via three possible routes. These are the ascending, haematogenous and 
lymphatic pathways. The ascending pathway involves colonization of the urethra with 
bacteria. Microorganisms in the urine can enter the bladder. Once in the bladder, bacteria 
can multiply and pass up the ureters to the renal pelvis and parenchyma. The 
haematogenous pathway involves infection of the renal parenchyma by blood-borne 
organisms. The organisms most often implicated here are S. aureus and Candida species. In 
humans, infection of the kidney via the haematogenous route rarely involves gram-negative 
bacilli. Lymphatic pathway infection occurs when increased pressure in the bladder can 
cause lymphatic flow to be directed to the kidneys taking with it microorganisms (Mandell, 
Bennett et al. 2005).  
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3.2.3 Clinical manifestations 
Urinary tract infection may involve the lower urinary tract or both the upper and lower 
urinary tracts. Lower urinary tract symptoms as a result from bacteria-producing irritation 
of the urethral and vesicle mucosa. This may cause frequent and painful urination of small 
amounts of urine that is turbid, suprapubic heaviness or pain and in some cases blood in the 
urine. Upper urinary tract infection includes fever, flank pain as well as symptoms such as 
increased frequency of urine, dysuria and the urgency to urinate. However these symptoms 
may vary greatly (Mandell, Bennett et al. 2005). Urinary tract infections in HIV-infected 
individuals include HIV-associated nephropathy, as well as skin and soft tissue infections 
(Eulalia Valencia, Enriquez et al. 1997).  
3.2.4 Management 
All symptomatic urinary tract infections should be treated whereas asymptomatic infection 
should be treated if at least two cultures of clean-voided, midstream urine grow the same 
organism in significant cell counts.  
A high fluid intake is recommended resulting in a dilution of the bacteria in the urine. 
Rapid hydration may reduce bacterial counts but this usually returns to normal once 
hydration is stopped. Decreasing the urinary pH results in antibacterial activity e.g. 
ingesting large volumes of cranberry juice contributes to low pH as high concentrations of 
hippuric acid (derived from the precursors in the berry) penetrates into the bacterial cell 
preventing optimal functioning. Hippuric acid is a weakly ionisable organic acid and is 
therefore able to better penetrate bacterial cells. Analgesics may be administered to 
patients exhibiting pain. 
Antimicrobial therapy is effective and guidelines are based on local antibiotic susceptibility 
patterns. However, antimicrobial drugs may either cure the infection or may cause bacterial 
persistence, relapse or re-infection. Bacterial cell counts should be reduced within 48 hours 
after the initiation of treatment with the antimicrobial drug that the microorganism is 
sensitive to in vitro. Bacteriologic cure is expected when the urine cultures are negative after 
48 hours of initial treatment and during the follow-up period of 1-2 weeks. Bacteriologic 
persistence occurs when bacterial counts are not reduced after 48 hours of treatment 
initiation or if the infecting organism persists in low numbers in the urine after 48 hours. 
Bacteriologic relapse occurs within 1-2 weeks after treatment has ended. Re-infection occurs 
during the administration of the drug or anytime thereafter. This is referred to as 
superinfection and may be identified by a change in bacterial species.  
Individuals that are severely ill with pyelonephritis should be hospitalised and parenteral 
therapy is required.  
For hospitalised immunocompromised patients with infections caused by gram-negative 
bacteria, third generation cephalosporins, aminopenicillin inhibitor combinations and 
carbapenems may be used with or without aminoglycosides and fluoroquinolones are 
recommended.  
3.3 Respiratory tract infections  
Nosocomial pulmonary infections are more common in patients with AIDS and are related 
to the extent of immunosuppression, prior use of antibiotics, and the exposure to invasive 
procedures. Nosocomial Mycobacterium tuberculosis and bacterial pneumonia are common in 
HIV-positive individuals and are associated with significant morbidity and mortality 
(Petrosillo, Nicastri et al. 2005). The majority of tuberculosis cases and deaths occur in low 
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resource areas; however nosocomial transmission to the patients with HIV occurs in both 
developed and developing countries mainly including multiple-drug resistant tuberculosis. 
3.3.1 Pneumonia 
Nosocomial pneumonia is the second leading cause of nosocomial infection and the leading 
cause of infection-related deaths in hospitalised patients (Mandell, Bennett et al. 2005). The 
morbidity associated with nosocomial pneumonia includes longer hospitalised stays and 
higher costs for health care (Wenzel 1989). Risk factors associated with nosocomial pneumonia 
are related to the patient’s immune status, infection-control practices and introduction of 
invasive procedures or other intervention (American Thoracic Society 1996). Patient-related 
risk factors are: age greater than 70 years, malnutrition, coma, metabolic acidosis, severe 
underlying disease and the presence of any of a number of co-morbid illnesses such as 
alcoholism, central nervous system dysfunction, and azotemia. Infection-control-related risk 
factors are a lack of hand hygiene, a lack of glove-use practices and the use of contaminated 
respiratory equipment. Intervention-related risk factors include procedures and treatment that 
may challenge normal host defenses or allow exposure of the host to large inocula of bacteria. 
Sedatives and narcotics may be aspirated, cytotoxic agents and corticosteroids may inhibit the 
hosts normal responses to infection and prolonged use of antimicrobials may lead to the 
development of drug resistance. Surgical procedures associated with the chest and abdomen 
may predispose the patient to pneumonia as these are associated with changes in host defense. 
Ventilation is also a major risk factor for the development of pneumonia in intensive care units 
(Craven and Steger 1995; George 1995). Pneumonia often affects individuals with impaired 
host defense systems such as defects in antibody production, phagocytosis, ciliary function or 
decreased CD4+ T-lymphocyte counts as seen in AIDS (Braunwald, Fauci et al. 2004). 
3.3.1.1 Etiological agents 
Reports of an increased risk of nosocomial respiratory tract infections due to aerobic gram-
positive and negative bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, 
Pseudomonas aeruginosa, Haemophilus influenzae and members of the enterobacteriaceae such 
as Klebsiella pneumoniae, Escherichia coli, Serratia marcescens, Enterobacter species in patients 
with HIV have been observed most frequently. Mortality rates are especially high in patients 
that have pneumonia caused by Pseudomonas aeruginosa or Acinetobacter species (Kollef, Bock 
et al. 1995; Tumbarello, Tacconelli et al. 1998; Mandell, Bennett et al. 2005). Anaerobic 
bacteria have been isolated from a number of patients with nosocomial pneumonia but only 
a small percentage of these cases are thought to be caused by these organisms (A'Court and 
Garrard 1992). Legionella species have also occasionally found to be the cause of nosocomial 
pneumonia and majority of these cases have been in immunocompromised individuals 
(Mandell, Bennett et al. 2005).  
3.3.1.2 Clinical manifestations 
Symptoms may vary and may be non-specific. Initial symptoms include fever, chills and 
malaise. Progressive anorexia and weight loss is usually indicative of chronic illness. 
Pulmonary symptoms may initially occur but as the illness progresses, this may become more 
frequent. Patients presenting with prolonged illness and nonspecific complaints together with 
pulmonary symptoms including shortness of breath, increased respiratory rate, sputum 
production, new or persistent cough, hemoptysis, chest pain or dyspnea should be evaluated. 
Extrapulmonary symptoms may also occur. Chronic pneumonia may present with skin and 
mucous membrane lesions suggesting histoplasmosis, coccidioidomycosis, blastomycosis and 
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in some epidemiologic settings paracoccidioidomycosis and may be differential in nosocomial 
settings. Cryptococcosis, nocardiosis and Karposi’s sarcoma are important considerations in 
AIDS patients (Mandell, Bennett et al. 2005; Raghavendran, Mylotte et al. 2007). 
3.3.1.3 Management 
Important considerations for the treatment of nosocomial pneumonia include early 
administration of the appropriate antibiotic (Iregui, Ward et al. 2002). Delay or 
inappropriate antibiotic treatment results in increased morbidity and mortality. Timely, 
accurate and appropriate therapy is therefore of vital importance as overuse or the 
unnecessary use of broad-spectrum antibiotics may result in drug resistance, superinfection 
and increased drug toxicity rates resulting in an increase in morbidity and mortality 
(Raghavendran, Mylotte et al. 2007). Ventilator-associated pneumonia is common. The 
antibiotic therapy that is employed depends on the use of prior antibiotic treatment at the 
time of onset of ventilator-associated pneumonia. If there is no prior history of antibiotic 
usage for early onset ventilator-associated pneumonia, third and fourth generation 
cephalosporins such as ceftriaxone or cefotaxime are the preferred choices or alternatively 
fluoroquinolones and or macrolides as part of combination treatment. An antipseudomonad 
cephalosporin such as ceftazadime or cefipime, an antipseudomonad penicillin such as 
piperacillin, carbepenem such as imipenem or meropenem or aztreonam combined with an 
aminoglycoside either in the presence or absence of methicillin-resistant S. aureus coverage 
with vancomycin or linezolid particularly if gram-positive cocci have been identified in the 
sputum Gram-stain, may be an effective combined regimen for the treatment of late-onset 
ventiliator-associated pneumonia (Ost, Hall et al. 2003).  
4. Intensive Care Unit (ICU) – Nosocomial infections in HIV-infected patients 
Nosocomial infection rates are highest in patients from intensive care units (ICU) and 
infection rates in adult and paediatric ICUs are about three fold higher than elsewhere in the 
hospital. The sites of infection and pathogens involved vary depending on the type of ICU 
treatment (Fridkin, Welbel et al. 1997; Weinstein 1998). Since the beginning of the AIDS 
epidemic, admissions in the ICU of hospitals have markedly increased with HIV-infected 
patients being admitted with concomitant infections such as pneumocystis pneumonia, 
bacterial pneumonia and tuberculosis – all of which are important infectious causes of 
respiratory failure resulting in pulmonary disease.  
Pseudomonas aeruginosa and Staphylococcus aureus as noted previously, are particularly 
significant causes of nosocomial bacterial pneumonias in ICU in both HIV-infected and HIV-
uninfected patients. Therefore the management of hospital-acquired and ventilator-associated 
pneumonia is similar for both group of patients (American Thoracic Society 2005). However, 
the presence of methicillin-resistant S. aureus is an independent risk factor for death in HIV-
infected patients and this should be considered in the initial treatment regimens (Franzetti, 
Grassini et al. 2006). Urinary tract infections in the ICU are as a result of fungal infections. 
Candida species including Candida albicans are the main cause of urinary tract infections in the 
ICU (Fridkin, Welbel et al. 1997). Another major cause of ICU admissions in HIV-infected 
patients is sepsis (Huang, Quartin et al. 2006; Japiassu, Amancio et al. 2010). Patients with 
invasive catheters and monitoring devices are predisposed to bloodstream infections caused 
by coagulase-negative staphylococci. Reports from one study demonstrated a 50% mortality 
rate in HIV-infected sepsis patients in ICU. The lung was the most common site of infection in 
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this study followed by primary bloodstream infections, venous catheter-related bacteraemia 
and urinary tract infections. Nosocomial infections were source of the sepsis and accounted for 
90% of cases in this cohort and were composed mostly of gram-negative rods such as 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, Escherichia coli, Acinetobacter 
species, Serratia marcescens, Staphylococcus species, Stenotrophomonas maltophilia, Clostridium 
difficile, Citrobacter freundii, Burkholderia cepacia and Candida species. Mycobaterium tuberculosis 
was the etiologic agent in some cases. The CD4 count of the patients in this cohort was very 
low. This could be associated with greater use of antibiotics for opportunistic infections or 
bacterial infections resulting in antibiotic resistance and consequently contributing to the 
development of nosocomial infections (Japiassú, Amâncio et al. 2010). It is challenging for 
clinicians practicing in the ICU setting to balance the need for providing adequate 
antimicrobial treatment to potentially infected individuals with the risks of overuse or 
unnecessary use of antibiotics. Most intensive care units have adopted the following strategy – 
to initiate broad-spectrum antibiotics followed by the appropriate antibiotic for the specific 
organism once identified and antimicrobial susceptibility testing is released (Ibrahim, Sherman 
et al. 2000). Comparison in characteristics of nososcomial infections between HIV positive 
verses. HIV negative patients is presented in Table 1.  
 
Nosocomial 
Infections  
HIV positive patients HIV negative patients 
Rate Common organisms Rate Common organisms 
Bacteraemia Increased in 
patients with 
central venous 
catheter and a 
high proportion 
of resistant K. 
pneumoniae
Coagulase-negative 
staphylococci 
Staphylococcus aureus, 
Klebsiella pneumoniae, 
Candida species, Salmonella 
species 
Lower mortality in 
HIV negative 
patients 
Staphylococcus aureus, 
Escherichia coli, 
Klebsiella pneumoniae 
Urinary 
tract 
infections  
Higher in 
catheterized 
patients and 
associated with 
nephropathy  
Staphylococci, enterococci, 
Proteus, Klebsiella, 
Enterobacter, Pseudomonas 
species and Candida 
species 
High in 
catheterized 
patients  
Staphylococci, 
enterococci, Proteus, 
Klebsiella, Enterobacter 
and Pseudomonas 
species 
Pneumonia The highest rate 
among all 
nosocomial 
infections and 
mostly 
increased in 
patients with 
CD4 
lymphocyte T 
count < 200 
cell/m3 
Mycobacterium tuberculosis, 
Pneumocystis jiroveci, 
Staphylococcus aureus, 
Streptococcus pneumoniae, 
Pseudomonas aeruginosa, 
Haemophilus influenzae and 
members of the 
enterobacteriaceae such as 
Klebsiella pneumoniae, 
Escherichia coli, Serratia 
marcescens, Enterobacter 
species 
Higher in the 
patients with risk 
factors such as: 
age >65, 
malnutrition, 
severe underlying 
diseases and 
patients with 
alcohol abuse  
Staphylococcus aureus, 
Streptococcus 
pneumoniae, 
Pseudomonas aeruginosa, 
Haemophilus influenzae 
and members of the 
enterobacteriaceae 
such as Klebsiella 
pneumoniae, Escherichia 
coli, Serratia marcescens, 
Enterobacter species 
Intensive 
Care Units 
(ICUs) 
More severe and 
increased in 
HIV/AIDS 
patients 
As above Higher in patients 
with risk factors 
and prolonged 
duration of stay 
As above 
Table 1. Characteristics of nosocomial infections between HIV positive and negative patients. 
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5. Hospital infection control 
In any society, health is a priority and infections particularly infections acquired in the 
hospital setting are a significant cause of disease worldwide. It is therefore imperative that 
the correct measures to control such infections are structured accordingly. These include an 
individual commitment by healthcare workers ensuring careful hand washing, appropriate 
isolation and use of gloves and the proper and sterile use of medical devices. System issues 
also need to be addressed – soap and water need to be available and placed at convenient 
locations easily accessible to healthcare workers. Surgical patients need to be administered 
pre-operative antibiotics 1-2 hours prior to incision and patients with communicable 
diseases need to be isolated. In addition, a good starting point for an infection control 
programme is basic surveillance thereby allowing for the calculation of the rates of 
infections. The role of such a programme is to provide local data and can be very effective in 
tracking the spread of nosocomial infections (Wenzel, Bearman et al. 2008). This would 
allow infection control personnel to rationally identify potential sources of pathogens and 
aid infectious disease physicians in the development of treatment regimens to manage 
patients affected by the related organisms (Singh, Goering et al. 2006). 
6. Conclusion 
Nosocomial infections are a serious problem that are continually increasing and expanding 
creating a severe public health threat and exhaust the health budget. In 
immunocompromised HIV-infected patients this threat is further amplified. However there 
are publications readily available indicating increased rates of nosocomial infections in HIV-
infected patients. There is a enormous array of factors that need to be taken into 
consideration when confronted with such infections. The importance of knowing the risk 
factors, etiological agents and antimicrobial susceptibility are essential and should not be 
underestimated. The lifesaving role of antiretroviral therapy has improved and prolonged 
the survival outcome but some dilemmas around chronic HIV infections persist. It may be 
related to the lack of case control studies that directly indicate relationship amongst 
nosocomial infections and HIV/AIDS. Importantly, in nosocomial settings ongoing infection 
control measures warrant prompt attention.  
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